EVERETT HARRIS & CO /CA/ - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
EVERETT HARRIS & CO /CA/ ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$8,0000.0%10,0020.0%0.00%
Q4 2021$8,000
-33.3%
10,0020.0%0.00%
Q3 2021$12,000
-25.0%
10,0020.0%0.00%
Q2 2021$16,000
-33.3%
10,0020.0%0.00%
Q1 2021$24,000
-20.0%
10,0020.0%0.00%
-100.0%
Q4 2020$30,000
+100.0%
10,0020.0%0.00%
Q3 2020$15,000
-40.0%
10,0020.0%0.00%
-100.0%
Q2 2020$25,000
+25.0%
10,0020.0%0.00%0.0%
Q1 2020$20,000
-35.5%
10,0020.0%0.00%0.0%
Q4 2019$31,000
-6.1%
10,0020.0%0.00%0.0%
Q3 2019$33,000
+3.1%
10,0020.0%0.00%0.0%
Q2 2019$32,000
+10.3%
10,0020.0%0.00%0.0%
Q1 2019$29,000
-27.5%
10,0020.0%0.00%0.0%
Q4 2018$40,000
-14.9%
10,0020.0%0.00%0.0%
Q3 2018$47,000
-42.7%
10,0020.0%0.00%
-50.0%
Q2 2018$82,000
+95.2%
10,0020.0%0.00%
+100.0%
Q1 2018$42,000
+27.3%
10,0020.0%0.00%0.0%
Q4 2017$33,000
+83.3%
10,0020.0%0.00%0.0%
Q3 2017$18,000
+63.6%
10,0020.0%0.00%
Q2 2017$11,000
-21.4%
10,0020.0%0.00%
Q1 2017$14,000
+16.7%
10,0020.0%0.00%
Q4 2016$12,000
+9.1%
10,0020.0%0.00%
Q3 2016$11,000
-8.3%
10,0020.0%0.00%
Q2 2016$12,000
+9.1%
10,0020.0%0.00%
Q1 2016$11,000
+10.0%
10,0020.0%0.00%
Q4 2015$10,000
-9.1%
10,0020.0%0.00%
Q3 2015$11,000
-38.9%
10,0020.0%0.00%
-100.0%
Q2 2015$18,000
+20.0%
10,0020.0%0.00%0.0%
Q1 2015$15,000
+15.4%
10,0020.0%0.00%
Q4 2014$13,000
-27.8%
10,0020.0%0.00%
-100.0%
Q3 2014$18,0000.0%10,0020.0%0.00%0.0%
Q2 2014$18,00010,0020.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders